Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) FCF Margin (2021 - 2025)

Mirum Pharmaceuticals (MIRM) has 5 years of FCF Margin data on record, last reported at 3.67% in Q4 2025.

  • For Q4 2025, FCF Margin rose 879.0% year-over-year to 3.67%; the TTM value through Dec 2025 reached 10.53%, up 776.0%, while the annual FY2025 figure was 10.53%, 776.0% up from the prior year.
  • FCF Margin reached 3.67% in Q4 2025 per MIRM's latest filing, down from 29.69% in the prior quarter.
  • Across five years, FCF Margin topped out at 29.69% in Q3 2025 and bottomed at 1056.41% in Q4 2021.
  • Average FCF Margin over 5 years is 152.83%, with a median of 38.18% recorded in 2023.
  • Peak YoY movement for FCF Margin: skyrocketed 93273bps in 2022, then crashed -2375bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 1056.41% in 2021, then surged by 88bps to 123.67% in 2022, then skyrocketed by 81bps to 23.89% in 2023, then skyrocketed by 79bps to 5.12% in 2024, then soared by 172bps to 3.67% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 3.67% in Q4 2025, 29.69% in Q3 2025, and 9.32% in Q2 2025.